Eli Lilly's growth should accelerate now that shortages of its GLP-1 drugs are resolved, but competitors are coming. More
Articles
GME Stock Warning: 2 Big Reasons Why GameStop Still Looks Like a Sell
Let's dive into a couple key reasons why GameStop's previous rallies look unlikely to continue, and why GameStop stock may be a top sell here. More
The 3 Best Auto Stocks to Buy in August 2024
These three auto stocks to buy offer healthy upside potential ahead, with encouraging operating performances and strong financial health More
Looking for Passive Income? Relax and Check Out High Yield MLPs
These high yield MLPs benefit from the liquidity of publicly traded companies while enjoying tax benefits of a private partnership. More
Why Is Outset Medical (OM) Stock Down 34% Today?
Outset Medical stock is dropping hard on Thursday as OM investors react to the company's lackluster earnings report for Q2. More
Why Is Cardlytics (CDLX) Stock Down 57% Today?
Cardlytics stock is down as CDLX investors react to a mixed earnings report for Q2 and the company changing its CEO. More
Qualcomm Stock Analysis: Is QCOM a Buy, Sell or Hold Right Now?
Explore Qualcomm stock and its position in the semiconductor industry, with growth potential in AI and automotive sectors. More
